Health Catalyst, Inc. $HCAT is First Light Asset Management LLC’s 7th Largest Position

First Light Asset Management LLC raised its stake in Health Catalyst, Inc. (NASDAQ:HCAT) by 9.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 13,436,220 shares of the company’s stock after acquiring an additional 1,206,039 shares during the quarter. Health Catalyst makes up 3.6% of First Light Asset Management LLC’s holdings, making the stock its 7th biggest position. First Light Asset Management LLC owned approximately 19.00% of Health Catalyst worth $38,293,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of HCAT. AMH Equity Ltd increased its stake in shares of Health Catalyst by 54.5% during the 3rd quarter. AMH Equity Ltd now owns 660,000 shares of the company’s stock worth $1,881,000 after purchasing an additional 232,851 shares during the last quarter. Dynamic Technology Lab Private Ltd purchased a new position in Health Catalyst in the second quarter valued at approximately $73,000. HighMark Wealth Management LLC lifted its stake in Health Catalyst by 88.3% in the third quarter. HighMark Wealth Management LLC now owns 310,282 shares of the company’s stock valued at $884,000 after purchasing an additional 145,532 shares during the last quarter. Campbell & CO Investment Adviser LLC grew its holdings in Health Catalyst by 9.7% during the second quarter. Campbell & CO Investment Adviser LLC now owns 43,051 shares of the company’s stock valued at $162,000 after purchasing an additional 3,808 shares during the period. Finally, Invesco Ltd. grew its holdings in Health Catalyst by 9.0% during the second quarter. Invesco Ltd. now owns 106,368 shares of the company’s stock valued at $401,000 after purchasing an additional 8,769 shares during the period. 85.00% of the stock is owned by institutional investors.

Key Headlines Impacting Health Catalyst

Here are the key news stories impacting Health Catalyst this week:

• Positive Sentiment: Revenue and some profitability metrics showed resilience: Q4 revenue slightly beat consensus ($74.68M vs. $73.99M) and the company reported full‑year revenue of $311.1M with Adjusted EBITDA of $41.4M — signals that core demand remains. Health Catalyst Reports Fourth Quarter and Year End 2025 Results
• Positive Sentiment: Some chart/analyst commentary suggests the stock may be finding technical support (hammer pattern) and that earnings‑estimate revisions could stabilize — a possible near‑term bottom for opportunistic buyers. HCAT May Find a Bottom Soon
• Neutral Sentiment: Management has launched a strategic review and the CEO would not rule out a potential sale — this could unlock value but also creates uncertainty around capital allocation and timing. Seeking Alpha: CEO declines to rule out sale
• Negative Sentiment: The quarter showed an EPS miss and continued negative margins — Q4 EPS missed estimates (reported ~$0.08 vs. consensus around $0.10), which undercut confidence in near‑term profitability. MarketBeat Q4 results summary
• Negative Sentiment: Q1 revenue guidance was lowered to $68.0M–$70.0M vs. consensus ~ $74.1M — the guidance shortfall appears to be the main driver of the selloff since it signals softer near‑term top‑line momentum. Earnings press release / guidance
• Negative Sentiment: Multiple sell‑side firms lowered price targets and moved to neutral/hold/equal‑weight (Citigroup to $1.75, Stephens and Stifel to $2.00), increasing downward pressure and reducing buy‑side conviction. Analyst price-target cuts (Benzinga)
• Negative Sentiment: Market reaction was amplified by heavy volume and headlines emphasizing the mixed print and management uncertainty, leading to sharp intraday selling despite the revenue beat. MSN: stock reaction

Health Catalyst Stock Performance

Shares of HCAT opened at $1.32 on Monday. Health Catalyst, Inc. has a 52-week low of $1.20 and a 52-week high of $5.06. The stock’s 50-day simple moving average is $2.05 and its 200 day simple moving average is $2.55. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.89 and a current ratio of 1.89. The stock has a market capitalization of $97.14 million, a price-to-earnings ratio of -0.52 and a beta of 1.77.

Health Catalyst (NASDAQ:HCAT) last posted its earnings results on Thursday, March 12th. The company reported $0.08 earnings per share for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.02). Health Catalyst had a negative net margin of 57.20% and a negative return on equity of 4.30%. The company had revenue of $74.68 million for the quarter, compared to analysts’ expectations of $73.99 million. Research analysts forecast that Health Catalyst, Inc. will post -0.33 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. Citigroup lowered their target price on Health Catalyst from $2.75 to $1.75 and set a “neutral” rating on the stock in a research note on Friday. Canaccord Genuity Group cut their price target on Health Catalyst from $5.00 to $2.00 and set a “buy” rating for the company in a research note on Friday. Stifel Nicolaus decreased their price objective on Health Catalyst from $3.75 to $2.00 and set a “hold” rating for the company in a report on Friday. Weiss Ratings restated a “sell (e+)” rating on shares of Health Catalyst in a research note on Monday, December 29th. Finally, Stephens dropped their price objective on shares of Health Catalyst from $3.50 to $2.00 and set an “equal weight” rating on the stock in a report on Friday. Five research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Health Catalyst has an average rating of “Hold” and a consensus target price of $3.16.

Health Catalyst Profile

Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment.